13 news items
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
TEVA
1 Jun 24
new Phase 3 RISE and SHINE analyses demonstrating no new or unexpected safety concerns in young adults with schizophrenia treated with UZEDY
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
TEVA
1 Jun 24
associated with Huntington's disease. Safety and effectiveness in pediatric patients have not been established. AUSTEDO XR is the once-daily formulation
Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
TEVA
29 May 24
for the treatment of tardive dyskinesia and for the treatment of chorea associated with Huntington's disease. Safety and effectiveness in pediatric
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
ALVO
TEVA
20 May 24
of this press release.
IMPORTANT SAFETY INFORMATION FOR SIMLANDI
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
ABBV
AMGN
CURLF
18 May 24
by licensed pharmacists, aiming to ensure patient safety and product consistency.
To learn more about all of this and how to invest
n2un5s38bek3kp3kltczgv42t27d5jmb0dux154x426du s6gsnivm69r3
TEVA
8 May 24
.
The long-term safety of TEV-‘749 and the incidence of post-injection delirium/sedation syndrome (PDSS) are also being evaluated in the SOLARIS open
q8sjg45tr9gxriwil3k43le3x6oibbcf6p6e7naojb3bbmx9r8woc6ulf0s
TEVA
8 May 24
safety data is being collected as part of the long-term follow-up SOLARIS study
TEV-‘749 is being developed by Teva as a once-monthly
8ta8gw1e9pnio1n75
TEVA
8 May 24
/sedation syndrome (PDSS) observed to date: additional safety data is being collected as part of the long-term follow-up SOLARIS study
6qie2mwkkr7pz6gvlmrfqs7ncnbjxk0pvxiczrcefyr8hzn
TEVA
2 May 24
, environment and governance related strategies and goals; environmental risks; failure to comply with applicable environmental laws, health and safety
vna823knf2sf3k82 8sj1asy6
TEVA
16 Apr 24
Titration Kit in final START study resultsSTART study results further support real-world effectiveness, safety, adherence
c9xun7fi
TEVA
11 Apr 24
significance as set out apriori through hierarchical testing
AJOVY confirmed a favorable safety profile
vm1copfw5tczivq5fx6sa6a6zcdhliax24vvcavj cvg
TEVA
8 Apr 24
its efficacy and safety profile in adults with schizophrenia
ADVANCE, a global survey study, will also provide real-world findings on LAI utilization from healthcare professionals, caregivers and patients
s6e0txj54gace12gjc8o5ocqkax90 e7hb5690ux4hx7lxd8dx2hfjq9n4f
TEVA
6 Apr 24
include a new analysis from the Phase 3 RISE trial reinforcing its efficacy and safety profile in adults with schizophrenia
- Prev
- 1
- Next